Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3452-3456

  Koshiyama, Hiroyuki ^a,b   Shimono, Dai ^a   Kuwamura, Naomitsu ^a   Minamikawa, Jun ^a   Nakamura, Yoshio ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^b Hyogo Prefectural Amagasaki Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; SULFONYLUREA DERIVATIVE; THIAZOLIDINE DERIVATIVE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; LIPID; THIAZOLE DERIVATIVE;

ARTERY WALL; ARTICLE; ATHEROGENESIS; CAROTID ARTERY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; INTIMA; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THICKNESS; TUNICA MEDIA; ARTERIOSCLEROSIS; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PATHOLOGY;

ARTERIOSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0034920087     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.3452     Document Type: Article

References (24)

1. An antidiabetic thiazolinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
2. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
3. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle cell in rats
4. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus
5. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes
6. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ
7. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
8. Carotid arterial intimal-medial thickening and plaque formation in NIDDM
9. Effect of amlodipine on intima-media thickness ofcarotid artery in type 2 diabetes
10. Decrease in carotid intima-media thickness after one-year therapy with etidronate for osteopenia associated with type 2 diabetes
11. PPARγ agonists inhibit production of monocyte inflammatory cytokines
12. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
13. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte- derived macrophages
14. Peroxisome proliferator activated receptor activators target human endothelial cells to inhibit leukocyte endothelial cell interaction
15. Modulation of vascular inflammation in vitro and in vivo by Peroxisome proliferator-activated receptor-γ activators
16. Blood pressure lowering by pioglitazone: Evidence for a direct vascular effect
17. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
18. Inhibition of oxidation of low density lipoprotein by troglitazone
19. Troglitazone has a scavenger effect on reactive oxygen species
20. Peroxisome proliferator-activated receptor ligands inhibit development of atherosclerosis in LDL receptor-deficent mice
21. PPARγ mediated high-fat diet induced adipocyte hypertrophy and insulin resistance
22. Differentiation and reversal of malignant changes in colon cancer through PPARγ
23. Activators of the nuclear receptor PPARγ enhance colon polyp formation
24. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension